Fibrin-based biomaterials to deliver human growth factors

Thrombosis and Haemostasis

Volumn 89, Issue 3, 2003, Pages 573-582

  Wong, Catalina ^a   Inman, Elisabeth ^a   Spaethe, Reiner ^a   Helgerson, Sam ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Angiogenesis; Fibrin sealant; Fibrin(ogen); Growth factors; Wound healing

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; FIBRIN; FIBRIN GLUE; GROWTH FACTOR; PROTEIN; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN 121; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RESPONSE; DRUG TRANSPORT; ENDOTHELIUM CELL; FIBRIN CLOT; GROWTH STIMULATION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 0037340354     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613389     Document Type: Article

References (42)

1. Schlag G. The importance of fibrin in wound repair. In: Fibrin Sealant in Operative Medicine Otorhinolaryngology. G Schlag and H Redl eds: Springer-Verlag 1986; 3-12.
2. Clark RAF. Fibrin and wound healing. Ann N Y Acad Sci 2001; 936: 355-67.
3. Hench LH, Polak JM. Third-generation biomedical materials. Science 2002; 295: 1014-7.
4. MacPhee MJ, Singh MP, Brady Jr. R. Akhyani N, Liau G, Lasa Jr. C. Hue C, Best A, Drohan W, Fibrin sealant: A versatile delivery vehicle for drugs and biologics. In: Surgical Adhesives and Sealants - Current Technology and Applications. DH Sierra and R Saltz eds: Technomic Publishing Co. 1996; 109-20.
5. Kim WJH. Cellular signaling in tissue regeneration. Yonsei Med J 2000; 41: 692-703.
6. Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Annu Rev Med 1995; 46: 467-81.
7. Madri JA, Sankar S. Romanic AM. Angiogenesis. In: The Molecular and Cellular Biology of Wound Repair. RAF Clark ed: Plenum Press 1996; 355-72.
8. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-8.
9. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280: 1358-66.
10. Carmeliet P, Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol 1997; 273: H2091-H2104.
11. Martin P. Wound healing - Aiming for perfect skin regeneration. Science 1997; 276: 75-81.
12. Thomspon WD, McNally SJ, Ganesalingam N. Wound healing, fibrin, and angiogenesis. In: Molecular, Cellular, and Clinical Aspects of Angiogenesis. ME Maragoudakis ed: Plenum Press 1999; 161-72.
13. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 1990; 26: 119-128.
14. Van Hinsberg V, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acadi Sci 2001; 936: 426-37.
15. Sahni A, Odrljin T, Francois CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998; 273: 7554-9.
16. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cells proliferation. Blood 2000; 96: 3772-8.
17. Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR. Insulin-like growth factor-binding protein-3 binds to fibrinogen and fibrin. J Biol Chem 1999; 274: 30215-21.
18. Sierra DH. Fibrin Sealan adhesive systrems: A review of their chemistry, material properties, and clinical applications. J Biomater Appl 1993; 7: 309-52.
19. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: Current and potential clinical applications. Blood Coagul Fibrinolysis 1996; 7: 737-46.
20. Chibber BA, Deutsch DG, Mertz ET. Affinity chromatography of plasminogen. Methods Enzmol 1974; 34: 424-32.
21. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977; 20: 1-5.
22. Houck K, Leung D, Rowland A, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 23031-6037.
23. Lobb RR. Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 1988; 27: 2572-8.
24. Sahni A, Baker C, Sporn L, Francis CW. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation. Thromb Haemost 2000; 83: 736-41.
25. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002; 91: 25-31.
26. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heisohn H, Vandlen R, Ferrara N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996; 271: 7788-95.
27. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Farrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-8.
28. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-54.
29. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4: 1317-26.
30. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R. Sasse J, Klagburn MN. Endothelial cell-derived basic fibroblast growth factor, synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292-6.
31. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-9.
32. Villaschi S, Nicosia RF. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993; 143: 181-90.
33. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7: 52-62.
34. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingram E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956-64.
35. Parsons-Wingerter P, Elliott KE, Clark JI. Farr AG. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree. Arterioscler Thromb Vasc Biol 2000; 20: 1250-6.
36. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res 1993; 274: 163-72.
37. Hasimoto J, Kurosaka M, Yoshiya S, Hirohata K. Meniscal repair using fibrin sealant and endothelial cell growth factor. Am J Sports Med 1992; 20: 537-41.
38. Albes JM, Klenzner T, Kotzerke J, Thiedemann KU, Scafers H-J, Borst H-G. Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann Thorac Surg 1994; 57: 444-9.
39. Quirinia A, Viidik A. The effect of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischemic and normal incisional skin wounds. Scand J Plast Reconstr Hand Surg 1998; 32: 9-18.
40. Nakanishis R, Hashimoto M, Yasumoto K. Improved airway healing using basic fibroblast growth factor in a canine tracheal autotransplantation model. Ann Surg 1998; 227: 446-54.
41. Greisler HP. Growth factor release from vascular grafts. J Controlled Release 1996; 39: 267-280.
42. Lee RJ, Springe ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF Gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.